Introduction
Despite evidence supporting the effectiveness of diabetic retinopathy screening (DRS) in reducing the risk of sight loss, attendance for screening in particular demographic groups is often below recommended levels.1 Although adherence to screening recommendations is generally high in countries with universal health insurance coverage, there is considerable variability within population subgroups. For example, in Australia, DRS uptake in non-indigenous Australians was reported to be 53% compared with 78% of indigenous Australians.2 Only 38% of recent immigrants to Canada had at least one screening visit within 1 year of diagnosis compared with 51% of long-term residents.3
Understanding modifiable barriers and enablers to DRS is essential to develop tailored intervention strategies to improve screening uptake. There have been many studies internationally that have investigated the factors influencing DRS attendance.4 5 Barriers/enablers to attendance potentially operate at different levels, including the person with diabetes, the healthcare professional (HCP) or the healthcare system. Furthermore, factors influencing individual screening attendance are likely to differ according to the presence of variables that are known to impact on health equity, for example, type of diabetes, ethnicity or socioeconomic status.6–9 However, studies have often considered people with diabetes as a homogeneous group and relatively few studies have addressed barriers/enablers in particular population subgroups.
Another demographic group where adherence to DRS consistently falls below recommended levels is young adults (YAs) with diabetes aged under 35 years.10–13 Recent studies from the UK Diabetic Eye Screening Program (DESP) have shown that the time interval from registration with the screening program to DRS attendance is strongly age dependent.10 12 Time to first screening was significantly longer for the 18–34 year age group, with 70% meeting the requirement for routine annual screening and approximately 20% remaining unscreened 3 years after registration.12 In terms of ongoing attendance, it was reported that younger adults (<35 years) have a 75% reduction in the odds of attending annual DRS compared with those aged 60 years and over.12 Furthermore, younger adults are more likely to miss three successive DRS appointments and present with sight-threatening retinopathy.13
YAs are a particularly hard to reach group and there has been little previous research to understand the reasons for poor DRS attendance in YAs.14 A 2017 Australian study15 conducted semistructured interviews with YAs, n=10 aged 18–39 years and older adults, n=20 aged over 40 years with type 2 diabetes (T2D). This study used a behavioral science framework, the Theoretical Domains Framework (TDF),16 to explore the wide range of barriers and enablers to attendance. The TDF synthesizes constructs from 33 theories of behavior change into 14 domains, representing individual, sociocultural and environmental influences on behavior (eg, knowledge, emotions, social and professional identity, perceived consequences, intention, environmental context and resources). Although younger and older adults shared several screening behavior determinants, a number of TDF domains showed greater salience to YAs including misconceptions regarding diabetic retinopathy (Knowledge); social comparison with others; unrealistic optimism and perceived invulnerability (Beliefs about consequences); and lack of time and financial resources (Environmental context and resources).15 We have recently completed the National Institute for Health and Care Research (NIHR)-funded ‘Enabling diabetic RetinOpathy Screening: Mixed methods study of barriers and enablers to attendance (EROS study)’, which aimed to identify barriers and enablers to DRS attendance experienced by YAs with diabetes living in the UK. As part of this research, we conducted qualitative interviews with 29 YAs with type 1 diabetes (T1D) aged 18–34 years.17 We have also conducted a cross-sectional survey of HCPs working in the UK National Diabetic Eye Screening Program.18 We similarly applied the TDF to identify modifiable barriers and enablers to DRS attendance. In terms of the interviews, key influences fell within the TDF domains: Knowledge, for example, not understanding reasons for attending DRS or treatments available if diabetic retinopathy is detected; Social support, for example, lack of support following DRS results; Social role and identity, for example, not knowing other people their age with diabetes; feeling ‘isolated’ and being reluctant to disclose their diabetes; Environmental context and resources, for example, lack of appointment flexibility and options for rescheduling; and Emotion, for example, diabetes distress/burnout. Enablers included Social influences, for example, support of family/diabetes team; and Goals, for example, DRS regarded as ‘high priority’. Barriers/enablers were generally consistent across groups defined by patterns of attendance (regular attenders, occasional non-attenders, regular non-attenders).
In the current study, we used the results of the previous interview study17 to further explore the research problem. Themes from the qualitative data informed the design of an online survey. The purpose of the survey was threefold: (1) to assess the generalizability of the perceived barriers and enablers in a larger and more diverse sample of YAs with regard to particular demographic characteristics (eg, age, employment, gender, ethnicity, educational level); (2) to enable a qualitative investigation of differences in perceived barriers and enablers between YAs with T1D and T2D; and (3) to investigate differences in those that attend DRS regularly versus those who did not. The survey also allowed us to triangulate findings from qualitative and quantitative methods to gain a more complete picture of the factors that influence screening uptake in YAs.19